Department of Molecular Cell Biology and Immunology, Amsterdam UMC, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands.
Division of Neuroscience, Department of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, Burlington Danes Building, Du Cane Road, London, W12 0NN, UK.
Acta Neuropathol. 2021 Jun;141(6):881-899. doi: 10.1007/s00401-021-02293-4. Epub 2021 Mar 29.
Meningeal inflammation strongly associates with demyelination and neuronal loss in the underlying cortex of progressive MS patients, thereby contributing significantly to clinical disability. However, the pathological mechanisms of meningeal inflammation-induced cortical pathology are still largely elusive. By extensive analysis of cortical microglia in post-mortem progressive MS tissue, we identified cortical areas with two MS-specific microglial populations, termed MS1 and MS2 cortex. The microglial population in MS1 cortex was characterized by a higher density and increased expression of the activation markers HLA class II and CD68, whereas microglia in MS2 cortex showed increased morphological complexity and loss of P2Y12 and TMEM119 expression. Interestingly, both populations associated with inflammation of the overlying meninges and were time-dependently replicated in an in vivo rat model for progressive MS-like chronic meningeal inflammation. In this recently developed animal model, cortical microglia at 1-month post-induction of experimental meningeal inflammation resembled microglia in MS1 cortex, and microglia at 2 months post-induction acquired a MS2-like phenotype. Furthermore, we observed that MS1 microglia in both MS cortex and the animal model were found closely apposing neuronal cell bodies and to mediate pre-synaptic displacement and phagocytosis, which coincided with a relative sparing of neurons. In contrast, microglia in MS2 cortex were not involved in these synaptic alterations, but instead associated with substantial neuronal loss. Taken together, our results show that in response to meningeal inflammation, microglia acquire two distinct phenotypes that differentially associate with neurodegeneration in the progressive MS cortex. Furthermore, our in vivo data suggests that microglia initially protect neurons from meningeal inflammation-induced cell death by removing pre-synapses from the neuronal soma, but eventually lose these protective properties contributing to neuronal loss.
脑膜炎症与进行性 MS 患者皮质下的脱髓鞘和神经元丢失密切相关,从而显著导致临床残疾。然而,脑膜炎症引起的皮质病变的病理机制在很大程度上仍未被揭示。通过对死后进行性 MS 组织中皮质小胶质细胞的广泛分析,我们确定了具有两种 MS 特异性小胶质细胞群体的皮质区域,分别称为 MS1 和 MS2 皮质。MS1 皮质中的小胶质细胞群体表现为更高的密度和激活标志物 HLA 类 II 和 CD68 的表达增加,而 MS2 皮质中的小胶质细胞表现出形态复杂性增加和 P2Y12 和 TMEM119 表达的丧失。有趣的是,这两种群体都与覆盖脑膜的炎症有关,并在进行性 MS 样慢性脑膜炎症的体内大鼠模型中得到时间依赖性复制。在这个最近开发的动物模型中,实验性脑膜炎症诱导后 1 个月的皮质小胶质细胞类似于 MS1 皮质中的小胶质细胞,而诱导后 2 个月的小胶质细胞获得了 MS2 样表型。此外,我们观察到 MS 皮质和动物模型中的 MS1 小胶质细胞都被发现紧密接近神经元胞体,并介导突触前位移和吞噬作用,这与神经元相对保留相一致。相比之下,MS2 皮质中的小胶质细胞不参与这些突触改变,但与大量神经元丢失有关。总之,我们的结果表明,在脑膜炎症的反应中,小胶质细胞获得两种不同的表型,它们与进行性 MS 皮质中的神经退行性变有不同的关联。此外,我们的体内数据表明,小胶质细胞最初通过从神经元胞体去除突触前体来保护神经元免受脑膜炎症诱导的细胞死亡,但最终失去这些保护特性,导致神经元丢失。